Complement Component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis.

Cited by (369)

Items 101–200 of 369

1. Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
   Tom Wei‐Wu Chen, I‐Shiow Jan, Dwang-Ying Chang, Ching‐Hung Lin, I‐Chun Chen, Ho‐Min Chen, Ann‐Lii Cheng, Yen‐Shen Lu · 2020 · Journal of Neuro-Oncology
2. The In Vivo Selection Method in Breast Cancer Metastasis
   Jun Nakayama, Yuxuan Han, Yuka Kuroiwa, Kazushi Azuma, Yusuke Yamamoto, Kentaro Semba · 2021 · International Journal of Molecular Sciences
3. Channeling Force in the Brain: Mechanosensitive Ion Channels Choreograph Mechanics and Malignancies
   Ali Momin, Shahrzad Bahrampour, Hyun-Kee Min, Xin Chen, Xian Wang, Yu Sun, Xi Huang · 2021 · Trends in Pharmacological Sciences
4. Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer
   Xiaochao Wang, Yan Hao, Jianfeng Chen, Peipei Ding, Xinyue Lv, Danlei Zhou, Ling Li, Luying Li, Yanqing Xu, Yumeng Zhu et al. · 2023 · Cell Death and Disease
5. Salting the Soil: Targeting the Microenvironment of Brain Metastases
   Ethan S. Srinivasan, Aaron C. Tan, Carey K. Anders, Ann Marie Pendergast, Dorothy A. Sipkins, David M. Ashley, Peter Edward Fecci, Mustafa Khasraw · 2021 · Molecular Cancer Therapeutics
6. The Yin Yang of Complement and Cancer
   Seppo Meri, Elena Illica Magrini, Alberto Mantovani, Cecília Garlanda · 2023 · Cancer Immunology Research
7. Complement and the hallmarks of cancer
   Mikel Rezola Artero, Andrea Minery, Leon Nedelcev, Maria Atanasova Radanova, Lubka T. Roumenina · 2025 · Seminars in Immunology
8. TAMs in Brain Metastasis: Molecular Signatures in Mouse and Man
   Michael Schulz, Lisa Sevenich · 2021 · Frontiers in Immunology
9. Complement and Cancer—A Dysfunctional Relationship?
   Joshua M. Thurman, Jennifer Laskowski, Raphael A. Nemenoff · 2020 · Antibodies
10. Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis
    Ludovica Mollica, Claudia Leli, Silvia Puglisi, Silvia Sardi, Federico Sottotetti · 2021 · Drugs in Context
11. Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype
    Amanda Fitzpatrick, Marjan Iravani, Adam Mills, David Vicente, Thanussuyah Alaguthurai, Ioannis Roxanis, Nicholas C. Turner, Syed Aleem Haider, Andrew N.J. Tutt, Clare M. Isacke · 2023 · Nature Communications
12. Immune surveillance of brain metastatic cancer cells is mediated by IFITM1
    Xiaofei She, Shijun Shen, Guang Chen, Yaqun Gao, Junxian Ma, Yaohui Gao, Yingdi Liu, Guoli Gao, Yan Fang Zhao, Chunyan Wang et al. · 2023 · The EMBO Journal
13. Review: Peering through a keyhole: liquid biopsy in primary and metastatic central nervous system tumours
    Luca Bertero, Giulia Siravegna, Roberta Rudà, Riccardo Soffietti, Alberto Bardelli, Paola Cassoni · 2019 · Neuropathology and Applied Neurobiology
14. The dual role of complement in cancers, from destroying tumors to promoting tumor development
    Ping Lü, Yifei Ma, Shaozhong Wei, Xinjun Liang · 2021 · Cytokine
15. Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases
    Jessica A. Wilcox, Adrienne Ann Boire · 2022 · CNS Drugs
16. Pediatric acute lymphoblastic leukemia—Conquering the CNS across the choroid plexus
    Martin März, Svenja Meyer, Ulrike Erb, Christina Georgikou, Martin A. Horstmann, Svetlana Hetjens, Christel Weiß, Petra Fallier‐Becker, Elodie Vandenhaute, Hiroshi Ishikawa et al. · 2018 · Leukemia Research
17. Clinical Perspectives in Brain Metastasis
    Krutika Deshpande, Ian A. Buchanan, Vahan Martirosian, Josh Neman · 2019 · Cold Spring Harbor Perspectives in Medicine
18. Dura immunity configures leptomeningeal metastasis immunosuppression for cerebrospinal fluid barrier invasion
    Jiaxu Zhao, Rui Zeng, Xiaohui Li, Ying Lu, Zuoyun Wang, Haibao Peng, Hao Chen, Minjie Fu, Y Z Zhang, Yang Huang et al. · 2024 · Nature Cancer
19. Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor Prognosis
    Rajia Bahri, Orsolya Kiss, Ian E. Prise, Karen M. Garcia‐Rodriguez, Haris Atmoko, Julia M. Martínez-Gómez, Mitchell Paul Levesque, Reinhard Dummer, Michael P. Smith, Claudia Wellbrock et al. · 2022 · Frontiers in Immunology
20. Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases
    Mariam Lotfy Khaled, Ahmad A. Tarhini, Peter A. Forsyth, Inna Smalley, Yolanda Piña · 2023 · Cancers
21. The choroid plexus stroma constitutes a sanctuary for paediatric B ‐cell precursor acute lymphoblastic leukaemia in the central nervous system
    Lidia M. Fernández-Sevilla, Jaris Valencia, Miguel A Flores‐Villalobos, África González‐Murillo, Rosa Sacedón, Eva Jiménez, Manuel R. Ramírez, Alberto Varas, Ángeles Vicente · 2020 · The Journal of Pathology
22. Potential benefit of osimertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
    Yali Yi, Jing Cai, Peng Xu, Le Xiong, Zhiqin Lu, Zhimin Zeng, Anwen Liu · 2022 · Journal of Translational Medicine
23. A novel therapeutic anti‑CD55 monoclonal antibody inhibits the proliferation and metastasis of colorectal cancer cells
    So Hee Dho, Eun Ju Cho, Ji Hyun Lee, So‑Young Lee, Sung Hoo Jung, Lark Kyun Kim, Jae Yol Lim · 2019 · Oncology Reports
24. Leptomeningeal metastases: the future is now
    Rimas Vincas Lukas, Jigisha P. Thakkar, Massimo Cristofanilli, Sunandana Chandra, Jeffrey Alan Sosman, Jyoti D. Patel, Priya Kumthekar, Roger Stupp, Maciej S. Lesniak · 2022 · Journal of Neuro-Oncology
25. Leptomeningeal Metastases
    Jerome J. Graber, Santosh Kesari · 2018 · Current Treatment Options in Oncology
26. The tumour microenvironment links complement system dysregulation and hypoxic signalling
    Monica M. Olcina, Ryan K. Kim, Stavros Melemenidis, Edward Elliot Graves, Amato J. Giaccia · 2018 · British Journal of Radiology
27. Management of leptomeningeal metastasis in breast cancer
    Hazem I. Assi, Tala Mahmoud, Fadi S. Saadeh, Haidar El Darsa · 2018 · Clinical Neurology and Neurosurgery
28. Targeting CNS Metastases in Non–Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers
    Jyoti Dhar Malhotra, Isa Mambetsariev, Gregory Gilmore, Jeremy Fricke, Arin Nam, N Gallego, Bihong T. Chen, Mike Y. Chen, Arya Amini, Rimas Vincas Lukas et al. · 2024 · JAMA Oncology
29. Cascade Catalytic Nanoparticles Selectively Alkalize Cancerous Lysosomes to Suppress Cancer Progression and Metastasis
    Limin Pan, Haibao Peng, Bowon Lee, Jiaxu Zhao, Xiulian Shen, Ximei Yan, Yipeng Hua, Jeonghyun Kim, Dokyoon Kim, Mouhong Lin et al. · 2023 · Advanced Materials
30. NSCLC Extracellular Vesicles Containing miR-374a-5p Promote Leptomeningeal Metastasis by Influencing Blood‒Brain Barrier Permeability
    Jie Jin, Yumeng Cui, Huicong Niu, Yanli Lin, Xiaojie Wu, Xuejiao Qi, Kaixuan Bai, Yu Zhang, Youliang Wang, Hui Bu · 2024 · Molecular Cancer Research
31. A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer
    Jiaojiao Deng, Sophia B. Chernikova, Yuelong Wang, Mirna L.M. Rodriguez, Stephanie Andersen, Maxine C. Umeh-Garcia, Bryanna Godfrey, Saman Seyed Ahmadian, Wolf-Nicolas Fischer, Kerry J. Koller et al. · 2021 · Molecular Cancer Therapeutics
32. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment
    Julian Steininger, Frank Friedrich Gellrich, Kay Engellandt, Matthias Meinhardt, Dana Westphal, Stefan Beissert, Friedegund Elke Meier, Isabella C. Glitza Oliva · 2023 · International Journal of Molecular Sciences
33. An Immunoregulatory Role for Complement Receptors in Murine Models of Breast Cancer
    Fazrena Nadia Md Akhir, Mohd Hezmee Mohd Noor, Keith Weng Kit Leong, Jamileh Nabizadeh, Helga D. Manthey, Stefan Sonderegger, Jenny N. Fung, Crystal McGirr, Ian A. Shiels, Paul Christian Mills et al. · 2021 · Antibodies
34. Leptomeningeal Disease: Current Approaches and Future Directions
    Ugur T. Sener, Jessica A. Wilcox, Adrienne Ann Boire · 2025 · Current Neurology and Neuroscience Reports
35. Brain Vascular Microenvironments in Cancer Metastasis
    Lucas E. Tobar, Rae H. Farnsworth, Steven A. Stacker · 2022 · Biomolecules
36. Insights into brain metastasis: Recent advances in circulating tumor cell research
    Remi V. Klotz, Min Yu · 2020 · Cancer Reports
37. Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway
    Huixue Wang, Jie Yang, Hui Pan, Mei-Chee Tai, Mohamed H. Maher, Renbing Jia, Shengfang Ge, Linna Lu · 2020 · OncoTargets and Therapy
38. Mouse Models of Metastasis and Dormancy
    Ahmed Mahmoud, Karuna Ganesh · 2023 · Cold Spring Harbor Perspectives in Medicine
39. Astrocyte Responses to Complement Peptide C3a are Highly Context-Dependent
    Marcela Pekna, Sumen Siqin, Yolanda de Pablo, Anna Stokowska, Åsa Torinsson Naluai, Milos Pekny · 2022 · Neurochemical Research
40. Genomic predictors of radiation response: recent progress towards personalized radiotherapy for brain metastases
    Paul M. Harary, Sanjeeth Rajaram, Maggie S. Chen, Yusuke S. Hori, David Jaehyun Park, Steven Daniel Chang · 2024 · Cell Death Discovery
41. Molecular Signature of Extracellular Vesicular Small Non-Coding RNAs Derived from Cerebrospinal Fluid of Leptomeningeal Metastasis Patients: Functional Implication of miR-21 and Other Small RNAs in Cancer Malignancy
    Kyue-Yim Lee, Yoona Seo, Ji Hye Im, Jiho Rhim, Woosun Baek, Sewon Kim, Ji-Woong Kwon, Byong Chul Yoo, Sang Hoon Shin, Heon Yoo et al. · 2021 · Cancers
42. A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma
    Vincent Law, Zhihua Chen, Francesca Vena, Inna Smalley, Robert J.B. Macaulay, Brittany R. Evernden, Nam Tran, Yolanda Piña, John Puskas, Gisela Cáceres et al. · 2022 · Neuro-Oncology
43. Hyperbaric oxygen therapy as an adjunt treatment for glioma and brain metastasis: a literature review
    Tengteng Cai · 2025 · Medical Gas Research
44. Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases
    J.A. Wilcox, Mark Yungjie Jeng, Samuel Tischfield, J.S.Y. Sui, D. Nemirovsky, Glenn Heller, Noura J. Choudhury, Jeff S. Ross, Charles M. Rudin, Gregory J. Riely et al. · 2025 · Annals of Oncology
45. Convergent cerebrospinal fluid proteomes and metabolic ontologies in humans and animal models of Rett syndrome
    Stephanie A. Zlatic, Duc Minh Duong, Kamal K.E. Gadalla, Brenda Murage, Lingyan Ping, Ruth Shah, James J. Fink, Omar Khwaja, Lindsay C. Swanson, Mustafa Şahin et al. · 2022 · iScience
46. Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective review
    Gerald Carter Wallace, Ronak Kundalia, Ethan J. Vallebuona, Biwei Cao, Youngchul Kim, Peter A. Forsyth, Aixa Elena Soyano, Inna Smalley, Yolanda Piña · 2024 · Breast Cancer Research
47. Metastatic medulloblastoma remodels the local leptomeningeal microenvironment to promote further metastatic colonization and growth
    Namal Abeysundara, Alexandra Rasnitsyn, Vernon Fong, Alexander T. Bahcheli, Randy Van Ommeren, Kyle Juraschka, Maria Claudia Vladoiu, Winnie Ong, Bryn G. Livingston, Pasqualino De Antonellis et al. · 2025 · Nature Cell Biology
48. Review of functional in vitro models of the blood-cerebrospinal fluid barrier in leukaemia research
    Ulrike Erb, Christian Schwerk, Horst Schroten, Michael Karremann · 2019 · Journal of Neuroscience Methods
49. Perspective: The role of mechanobiology in the etiology of brain metastasis
    Kandice Tanner · 2018 · APL Bioengineering
50. The genetic script of metastasis
    Goodwin G. Jinesh, Andrew Scott Brohl · 2019 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
51. Leptomeningeal anti-tumor immunity follows unique signaling principles
    Ján Remšík, Xinran Tong, Russell Kunes, Minjun Li, Ahmed M. Osman, Kiana Chabot, Ugur T. Sener, Jessica A. Wilcox, Danielle Isakov, Jenna Snyder et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
52. VLA-4 suppression by senescence signals regulates meningeal immunity and leptomeningeal metastasis
    Jiaqian Li, Di Huang, Bingxi Lei, Jingying Huang, Linbing Yang, Man Nie, Shicheng Su, Qiyi Zhao, Ying Wang · 2022 · eLife
53. Comparison of the diagnostic value of liquid biopsy in leptomeningeal metastases: A systematic review and meta-analysis
    Hanbin Wang, Luxuan Wang, Chuan Fang, Chunhui Li, Lijian Zhang · 2022 · Frontiers in Oncology
54. Hydrophilic Peptide and Glycopeptide as Immobilized Sorbents for Glycosylation Analysis
    Zhaoliang Liu, Zhen Wu, Yufeng Zhou, Jun Xia, Wenqi Zhang, Song Gao, Shuwei Li, Zhaohui Lu, Xumin Zhang, Shuang Yang · 2024 · Analytical Chemistry
55. Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy
    Clémence Dubois, Fanny Martin, Chervin Hassel, Florian Magnier, Pierre Daumar, Corinne Aubel, Sylvie Guerder, Emmanuelle Mounetou, Frederique Madeleine Penault-Llorca, Mahchid Bamdad · 2019 · Journal of Clinical Medicine
56. A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future
    Luke Maillie, Lucas Resende Salgado, Stanislav Lazarev · 2021 · Clinical & Translational Oncology
57. Leptomeningeal metastases from non-small cell lung cancer: state of the art and recent advances
    Alessia Pellerino, Valeria Internò, Erminia Muscolino, Francesca Mo, Francesco Bruno, Edoardo Pronello, Federica Franchino, Riccardo Soffietti, Roberta Rudà · 2020 · Journal of Cancer Metastasis and Treatment
58. Leptomeningeal Metastasis in ER + HER2- Advanced Breast Cancer Patients: A Review of the Cases in a Single Institute Over a 15-year Period
    Junichiro Watanabe, Koichi Mitsuya, Shogo Nakamoto, Hideyuki Harada, Shoichi Deguchi, Nakamasa Hayashi, Yoko Nakasu · 2021 · Breast Cancer Research and Treatment
59. Different Metabolomic and Proteomic Profiles of Cerebrospinal Fluid in Ventricular and Lumbar Compartments in Relation to Leptomeningeal Metastases
    Ji-Woong Kwon, Ji Hye Im, Kyue-Yim Lee, Byong Chul Yoo, Jun Hwa Lee, Kyung‐Hee Kim, Jong Heon Kim, Sang Hoon Shin, Heon Yoo, Ho‐Shin Gwak · 2022 · Metabolites
60. The evolving landscape of brain metastasis: volume II
    Manuel Valiente, Carey K. Anders, Adrienne Ann Boire, Benjamin Izar, Nuria Kotecki, Srinivas Malladi, Joan Massagué, Nelson S. Moss, Josh Neman, Matthias Preusser et al. · 2025 · Trends in cancer
61. Clinical efficacy and safety of different doses of intrathecal methotrexate in the treatment of leptomeningeal carcinomatosis: a prospective and single-arm study
    Lan Hou, Weixin Han, Jie Jin, Xin Chen, Yueli Zou, Li-Tian Yan, Junying He, Hui Bu · 2021 · Japanese Journal of Clinical Oncology
62. ICAM2 initiates trans-blood-CSF barrier migration and stemness properties in leptomeningeal metastasis of triple-negative breast cancer
    Jhih-Kai Pan, Wen-Der Lin, Yao‐Lung Kuo, Yu‐Chia Chen, Zhu-Jun Loh, Forn‐Chia Lin, Hui-Chuan Cheng, Michael Hsiao, Pei‐Jung Lu · 2023 · Oncogene
63. Spatial transcriptomics analysis identifies a tumor-promoting function of the meningeal stroma in melanoma leptomeningeal disease
    Hasan Alhaddad, Oscar E. Ospina, Mariam Lotfy Khaled, Yuan Ren, Ethan J. Vallebuona, Mohammad Baraa Boozo, Peter Forsyth, Yolanda Piña, Robert J.B. Macaulay, Vincent Law et al. · 2024 · Cell Reports Medicine
64. AptBCis1, An Aptamer–Cisplatin Conjugate, Is Effective in Lung Cancer Leptomeningeal Carcinomatosis
    Bo‐Tsang Huang, Wei‐Yun Lai, Chen-Lin Yeh, Yi‐Ting Tseng, Konan Peck, Pan‐Chyr Yang, Emily Pei-Ying Lin · 2024 · ACS Nano
65. Pathological Features of Brain Metastases
    Saber Tadros, Abhik Ray‐Chaudhury · 2020 · Neurosurgery Clinics of North America
66. Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysis
    David J. H. Bian, Anna-Maria Lazaratos, Sarah M. Maritan, Andrea Quaiattini, Zhimin Zeng, Zhengfei Zhu, Ugur T. Sener, Rachna Malani, Yu Jung Kim, Eiki Ichihara et al. · 2024 · Heliyon
67. Local and Cell-intrinsic complement: The new player in cancer progression
    Margot Revel, Nicolas S. Merle · 2025 · Seminars in Immunology
68. Leptomeningeal Carcinomatosis
    Sunny R. K. Singh, Sindhu Janarthanam Malapati, Ahmad Hatem Mattour · 2022 · Springer eBooks
69. Sodium to globulin ratio as a prognostic factor for patients with advanced gastric cancer
    Liqun Zhang, Zhuo Wang, Jiawen Xiao, Hao Chen, Zhiyan Zhang, Haijing Li, Yuanhe Wang, Haiyan Piao, Fang Li, Lisha Zhang et al. · 2020 · Journal of Cancer
70. Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases
    Mei-Mei Zheng, Yang-Si Li, Hai‐Yan Tu, Hao Sun, Kai Yin, Ben‐Yuan Jiang, Jin‐Ji Yang, Xu‐Chao Zhang, Qing Hua Zhou, Chong‐Rui Xu et al. · 2022 · BMC Medicine
71. Immunological and pathological characteristics of brain parenchymal and leptomeningeal metastases from non-small cell lung cancer
    Cheng Zhou, Shu Shan, Lei Wen, Da Liu, Changguo Shan, Xin Jin, Zhaoming Zhou, Hainan Li, Juan Li, Luyue Wang et al. · 2025 · Cell Discovery
72. Decoding the mechanisms underlying breast cancer brain metastasis: paving the way for precision therapeutics
    Xuanhe Zhang, Xiang Wang, Saimeng Shi, Duancheng Guo · 2025 · Biomarker Research
73. Metastasis manners and the underlying mechanisms of ALK and ROS1 rearrangement lung cancer and current possible therapeutic strategies
    Xing Chang, Zi Liu, Shuai Man, Annie Roys, Zengqiang Li, Daiying Zuo, Yingliang Wu · 2019 · RSC Advances
74. Stereotactic Radiosurgery for Intraventricular Metastases: A Multicenter Study
    Georgios Mantziaris, Stylianos Pikis, Zhiyuan Xu, Reed Mullen, Juan Diego Alzate, Kenneth Bernstein, Douglas S Kondziolka, Zhishuo Wei, Ajay Niranjan, L. Dade Lunsford et al. · 2022 · Neurosurgery
75. Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study
    Tijmen J.W.T. van der Wel, Mirjam C. Boelens, M. Jebbink, Sietske A. Smulders, Klaartje W. Maas, Merel J.A. Luitse, Annette Compter, Robin P B Boltjes, Nik Sol, Kim Monkhorst et al. · 2024 · Neuro-Oncology
76. Molecular Underpinnings of Brain Metastases
    Maria A. Jacome, Qiong Wu, Jianan Chen, Zaynab Sidi Mohamed, Sepideh Mokhtari, Yolanda Piña, Arnold B. Etame · 2025 · International Journal of Molecular Sciences
77. Pro‐ and Anti‐Inflammatory Role of Complement in Cancer
    Pradipta Pal, Praneet Wahi, Arvind Sahu, Girdhari Lal · 2025 · European Journal of Immunology
78. Complement C3a: Shaping the Plasticity of the Post-stroke Brain
    Anna Stokowska, Marcela Pekna · 2017 · Springer series in translational stroke research
79. Modulation of the Complement System by Neoplastic Disease of the Central Nervous System
    Steven K. Yarmoska, A. Alawieh, S. Tomlinson, K. Hoang · 2021 · Frontiers in Immunology
80. Integrins and the Metastasis-like Dissemination of Acute Lymphoblastic Leukemia to the Central Nervous System
    Signe Modvig, Jenani Jeyakumar, Hanne Vibeke Marquart, Claus Christensen · 2023 · Cancers
81. A Double‐Edged Sword: Complement Component 3 in Toxoplasma gondii Infection
    Wanyi Huang, Ya‐Pei Wang, Yasser S. Mahmmod, Junjie Wang, Tanghui Liu, Zheng Yu-Xiang, Xue Zhou, Xiu‐Xiang Zhang, Zi‐Guo Yuan · 2018 · PROTEOMICS
82. GYY4137 Attenuates Sodium Deoxycholate-Induced Intestinal Barrier Injury Both In Vitro and In Vivo
    Zeyang Chen, Jianqiang Tang, Pengyuan Wang, Jing Zhu, Yucun Liu · 2019 · BioMed Research International
83. Targeting the tissue-complosome for curbing inflammatory disease
    Kuheli Dutta, Jasna Friščić, Markus H. Hoffmann · 2022 · Seminars in Immunology
84. Complement system in tumor growth and metastases
    Tsvetan Borisov, Dimitar Metodiev, Dilyan Ferdinandov, Lubka T. Roumenina · 2025 · British Journal of Cancer
85. Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Release and Complement Activation in KRAS‐mutant Cancers
    Yafang Wang, Lansong Xu, Lijun Ling, Mingyue Yao, Shangxuan Shi, Chengcheng Yu, Yingnian Li, Jie Shen, Hualiang Jiang, Chengying Xie · 2024 · Advanced Science
86. Молекулярні механізми утворення метастазів. Маркери метастазування при карциномах щитоподібної залози (огляд літератури)
    P.P. Zinych, V.M. Pushkarev, М.Yu. Bolgov, B.B. Guda, VIKTOR V. PUSHKAREV · 2020 · Endokrynologia
87. Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
    Robert J. Vanner, Stephanie M. Dobson, Olga I. Gan, Jessica L. McLeod, Erwin M. Schoof, Ildiko Grandal, Jeff A. Wintersinger, Laura García‐Prat, Mohsen Hosseini, Stephanie Zhi-Juan Xie et al. · 2021 · Blood Cancer Discovery
88. Comprehensive analysis of differentially expressed profiles of long non-coding RNAs and messenger RNAs in kaolin-induced hydrocephalus
    Yan-Hui Shi, Xinwei He, Feng-Di Liu, Yi‐Sheng Liu, Yue Hu, Liang Shu, Guo-hong Cui, Rong Zhao, Lei Zhao, Jingjing Su et al. · 2019 · Gene
89. Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis
    Siyi Xiong, Xuanni Tan, Xiujuan Wu, Andi Wan, Guozhi Zhang, Cheng Wang, Yan Liang, Yi Zhang · 2023 · Therapeutic Advances in Medical Oncology
90. Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis
    Lan Hou, Xin Chen, Gang Qiu, Xuejiao Qi, Yueli Zou, Junying He, Hui Bu · 2023 · Journal of Neuro-Oncology
91. Single-cell transcriptomics reveals over-activated reactive oxygen species pathway in hepatocytes in the development of hepatocellular carcinoma
    Xiaoping Wang, Penghui Li, Huicong Ji, Zhenzhen Xu, Huiwu Xing · 2024 · Scientific Reports
92. Cerebral spinal fluid analyses and therapeutic implications for leptomeningeal metastatic disease
    Jie Wei Zhu, Megan Shum, Maleeha A. Qazi, Arjun Sahgal, Sunit Das, Matthew Dankner, Ines B. Menjak, Mary Jane Lim-Fat, Katarzyna Joanna Jerzak · 2024 · Journal of Neuro-Oncology
93. Fluid shear stress activates a targetable mechano-metastatic cascade to promote medulloblastoma metastasis
    Hyun-Kee Min, Hongyu Zhao, Alexander T. Bahcheli, Peng Pan, Jade Chan, Junsheng Chen, Esther Low, Yuxiao Zhou, Xian Wang, Savo Bajic et al. · 2025 · Nature Biomedical Engineering
94. Role of exosomal miRNAs in brain metastasis affected by radiotherapy
    Zihuang Li, Hongli Yang, Ling Ye, Rencui Quan, Meili Chen · 2021 · Translational Neuroscience
95. Progeny in an Inhospitable Milieu—Solitary Intraventricular Metastasis From a Triple-Negative Breast Cancer Mimicking Central Neurocytoma: Case Report and Review of Diagnostic Pitfalls and Management Strategies
    Saraswati Shenoy, Satyanarayana N. Shenoy · 2019 · World Neurosurgery
96. Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care
    Inna Smalley, Adrienne Ann Boire, Priscilla Kaliopi Brastianos, Harriet M. Kluger, Eva Hernando-Monge, Peter A. Forsyth, Kamran A. Ahmed, Keiran S.M. Smalley, Sherise Desiree Ferguson, Michael A. Davies et al. · 2023 · Pigment Cell & Melanoma Research
97. The Spectrum of Headache in Leptomeningeal Metastases: A Comprehensive Review with Clinical Management Guidelines
    Jessica A. Wilcox, Rachel Estrera, Adrienne Ann Boire · 2023 · Current Pain and Headache Reports
98. Histone variant H2AZ1 drives lung cancer progression through the RELA-HIF1A-EGFR signaling pathway
    Huijie Zhao, Xing Wu, Yinghan Wang, Xiuling Li, Yuhui Du, Zhiqing Zhou, Yu Li, Yue Liu, Xiaofei Zeng, Guoan Chen · 2024 · Cell Communication and Signaling
99. Role of GPX3+ astrocytes in breast cancer brain metastasis activated by circulating tumor cell exosomes
    Guanghui Huang, Gongwen Xu, Qianqian Cao, Sheng Li, Zhengwei Li, Xiaonan Zhang, Xiaomei Li · 2025 · npj Precision Oncology
100. Proteomic and In Silico Analyses Highlight Complement System’s Role in Bladder Cancer Immune Regulation
     Tuğcan Korak, İbrahim Halil Baloğlu, Murat Kasap, Elif Damla Arısan, Gürler Akpınar, Serdar Arısan · 2025 · Medicina